US2005080235A1PendingUtilityA1
Ret ligand (RetL) for stimulating neural and renal growth
Priority: May 8, 1996Filed: Sep 23, 2003Published: Apr 14, 2005
Est. expiryMay 8, 2016(expired)· nominal 20-yr term from priority
A61K 38/00C07K 14/71A61K 48/00C07K 2319/00C07K 14/47
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Nucleotide and amino acid sequences are provided for compounds which promote tissue growth, as well as methods for modulating tissue growth, for imaging tissues and organs, and for treating patients.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide comprising an amino acid sequence at least 80% identical to an amino acid sequence selected from the group consisting of SEQ ID No:17 and SEQ ID No:21, wherein said polypeptide interacts with a receptor protein Ret to trigger dimerization of the receptor protein Ret or autophosphorylation of a tyrosine kinase domain of the receptor protein Ret.
2 . The polypeptide of claim 1 , wherein the amino acid sequence is at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NO:17 and SEQ ID NO:21.
3 . An isolated polypeptide selected from the group consisting of SEQ ID No: 17 and SEQ ID No: 21.
4 . The polypeptide of claim 3 , wherein the amino acid sequence of the polypeptide is SEQ ID NO:21.Join the waitlist — get patent alerts
Track US2005080235A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.